Back to Journals » Drug Design, Development and Therapy » Volume 11

Review

Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: do we know enough?

       
Total article views   HTML views PDF downloads Totals
12,802 Dovepress* 10,686+ 1,226 11,912
PubMed Central* 2,116 393 2,509
Totals 12,802 1,619 14,421
*Since 11 October 2017

View citations on PubMed Central and Google Scholar